Leitlinie von DOG, RG und BVA: Retinale arterielle Verschlüsse (RAV)

DOG – Deutsche Ophthalmologische Gesellschaft

doi:10.1055/s-0042-124533

Klinische Monatsblätter für Augenheilkunde, Table of Contents

Klin Monbl Augenheilkd 2017; 234(03): 370-382
DOI: 10.1055/s-0042-124533

Leitlinie

Georg Thieme Verlag KG Stuttgart · New York

Leitlinie von DOG, RG und BVA: Retinale arterielle Verschlüsse (RAV)

DOG – Deutsche Ophthalmologische Gesellschaft

Abstract

Schlüsselwörter

Zentralarterienverschluss (ZAV) - Arterienastverschluss (AAV) - Verschluss einer zilioretinalen Arterie und Amaurosis fugax

Key words

central retinal artery occlusion (CRAO) - branch retinal artery occlusion (BRAO) - cilioretinal artery occlusion (CLRAO) - amaurosis fugax (AF)

Full Text

References

Literatur
1 Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 2001; 323: 334-336
2 Fraser SG, Adams W. Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev 2009; (01) CD001989
3 Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 2005; 24: 493-519
4 Hayreh SS. Acute retinal arterial occlusive disorders. Prog Retin Eye Res 2011; 30: 359-394
5 Duker JS, Sivalingam A, Brown GC, Reber R. A prospective study of acute central retinal artery obstruction. The incidence of secondary ocular neovascularization. Arch Ophthalmol 1991; 109: 339-342
6 Leavitt JA, Larson TA, Hodge DO, Gullerud RE. The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol 2011; 152: 820-823.e2
7 Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion.[erratum appears in Am J Ophthalmol 2000; 130: 908]. Am J Ophthalmol 1999; 128: 733-738
8 Rudkin AK, Lee AW, Chen CS. Central retinal artery occlusion: timing and mode of presentation. Eur J Neurol 2009; 16: 674-677
9 Karjalainen K. Occlusion of the central retinal artery and retinal branch arterioles. A clinical, tonographic and fluorescein angiographic study of 175 patients. Acta Ophthalmol (Copenh) 1971; 109: 1-96
10 Brown GC, Magargal LE. Central retinal artery obstruction and visual acuity. Ophthalmology 1982; 89: 14-19
11 Hayreh SS. Ocular vascular occlusive disorders: natural history of visual outcome. Prog Retin Eye Res 2014; 41: 1-25
12 Uhr JH, Mishra K, Wei C, Wu AY. Awareness and knowledge of emergent ophthalmic disease among patients in an internal medicine clinic. JAMA Ophthalmol 2016; 134: 424-431
13 Schmidt D, Schumacher M, Feltgen N. Circadian incidence of non-inflammatory retinal artery occlusions. Graefes Arch Clin Exp Ophthalmol 2009; 247: 491-494
14 Hayreh SS, Podhajsky PA, Zimmerman MB. Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology 2009; 116: 1928-1936
15 Hayreh SS, Zimmerman MB. Fundus changes in central retinal artery occlusion. Retina 2007; 27: 276-289
16 Wong TY, Klein R. Retinal arteriolar emboli: epidemiology and risk of stroke. Curr Opin Ophthalmol 2002; 13: 142-146
17 Naumann G. Pathologie des Auges. In: Naumann G. ed. Embryologie, Anatomie und Untersuchungstechnik. Vol. 1. 2nd ed.. Berlin: Springer; 1997: 1004-1008
18 Hayreh SS, Zimmerman MB. Amaurosis fugax in ocular vascular occlusive disorders: prevalence and pathogeneses. Retina 2014; 34: 115-122
19 Petzold A, Islam N, Hu H-H. et al. Embolic and nonembolic transient monocular visual field loss: a clinicopathologic review. Surv Ophthalmol 2013; 58: 42-62
20 Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome – a systematic review. Med Sci Monit Int Med J Exp Clin Res 2012; 18: RA138-144
21 Ness T, Bley TA, Schmidt WA. et al. The diagnosis and treatment of giant cell arteritis. Dtsch Ärztebl Int 2013; 110: 376-385 (quiz 386)
22 Brown GC, Magargal LE. The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol 1988; 11: 239-251
23 Duker JS, Cohen MS, Brown GC. et al. Combined branch retinal artery and central retinal vein obstruction. Retina 1990; 10: 105-112
24 Chen S-N, Hwang J-F, Chen Y-T. Macular thickness measurements in central retinal artery occlusion by optical coherence tomography. Retina Phila Pa 2011; 31: 730-737
25 Ritter M, Sacu S, Deák GG. et al. In vivo identification of alteration of inner neurosensory layers in branch retinal artery occlusion. Br J Ophthalmol 2012; 96: 201-207
26 Schmidt D, Kube T, Feltgen N. Central retinal artery occlusion: findings in optical coherence tomography and functional correlations. Eur J Med Res 2006; 11: 250-252
27 Chu YK, Hong YT, Byeon SH. et al. In vivo detection of acute ischemic damages in retinal arterial occlusion with optical coherence tomography: a “prominent middle limiting membrane sign”. Retina Phila Pa 2013; 33: 2110-2117
28 Dotan G, Goldenberg D, Kesler A. et al. The use of spectral-domain optical coherence tomography for differentiating long-standing central retinal artery occlusion and nonarteritic anterior ischemic optic neuropathy. Ophthalmic Surg Lasers Imaging Retina 2014; 45: 38-44
29 Brown GC, Magargal LE, Federman JL. Ischaemia and neovascularization. Trans Ophthalmol Soc U K 1980; 100: 377-380
30 Brown GC, Magargal LE, Simeone FA. et al. Arterial obstruction and ocular neovascularization. Ophthalmology 1982; 89: 139-146
31 Duker JS, Brown GC. Iris neovascularization associated with obstruction of the central retinal artery. Ophthalmology 1988; 95: 1244-1250
32 Hayreh SS, Podhajsky PA, Zimmerman MB. Branch retinal artery occlusion: natural history of visual outcome. Ophthalmology 2009; 116: 1188-1194 e1–e4
33 Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome. Am J Ophthalmol 2005; 140: 376-391
34 Mukhtyar C, Guillevin L, Cid MC. et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009; 68: 318-323
35 Ball EL, Walsh SR, Tang TY. et al. Role of ultrasonography in the diagnosis of temporal arteritis. Br J Surg 2010; 97: 1765-1771
36 Hunder GG, Bloch DA, Michel BA. et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-1128
37 Murchison AP, Gilbert ME, Bilyk JR. et al. Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis. Am J Ophthalmol 2012; 154: 722-729
38 BVA und DOG. Augenärztliche Basisdiagnostik bei Patienten ab dem 7. Lebensjahr. 1998 Im Internet: http://augeninfo.de/leit/leitlinie.php?nr=leit04 Stand: 04.01.2017
39 Watkinson S, Seewoodhary R. Administering eye medications. Nurs Stand R Coll Nurs G B 2008; 22: 42-48
40 Wong T, Mitchell P. The eye in hypertension. Lancet 2007; 369: 425-435
41 Rim TH, Han J, Choi YS. et al. Retinal artery occlusion and the risk of stroke development: Twelve-year nationwide cohort study. Stroke J Cereb Circ 2016; 47: 376-382
42 Chang Y-S, Jan R-L, Weng S-F. et al. Retinal artery occlusion and the 3-year risk of stroke in Taiwan: a nationwide population-based study. Am J Ophthalmol 2012; 154: 645-652.e1
43 Amarenco P, Lavallée PC, Labreuche J. et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med 2016; 374: 1533-1542
44 Park SJ, Choi N-K, Yang BR. et al. Risk and risk periods for stroke and acute myocardial infarction in patients with central retinal artery occlusion. Ophthalmology 2015; 122: 2336-2343
45 Callizo J, Feltgen N, Pantenburg S. et al. Cardiovascular risk factors in central retinal artery occlusion: results of a prospective and standardized medical examination. Ophthalmology 2015; 122: 1881-1888
46 Leisser C, Kaufmann TA, Feltgen N. et al. Distribution of internal carotid artery plaque locations among patients with central retinal artery occlusion in the Eagle study population. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Für Klin Exp Ophthalmol 2015; 253: 1227-1230
47 Rudkin AK, Lee AW, Chen CS. Vascular risk factors for central retinal artery occlusion. Eye (Lond) 2010; 24: 678-681
48 Hayreh SS. Pathogenesis of occlusion of the central retinal vessels. Am J Ophthalmol 1971; 72: 998-1011
49 Schmidt D, Hetzel A, Geibel-Zehender A. et al. Systemic diseases in non-inflammatory branch and central retinal artery occlusion – an overview of 416 patients. Eur J Med Res 2007; 12: 595-603
50 Hayreh SS, Kolder HE, Weingeist TA. Central retinal artery occlusion and retinal tolerance time. Ophthalmology 1980; 87: 75-78
51 Atebara NH, Brown GC, Cater J. Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion. Ophthalmology 1995; 102: 2029-2034 discussion 2034–2035
52 Augsburger JJ, Magargal LE. Visual prognosis following treatment of acute central retinal artery obstruction. Br J Ophthalmol 1980; 64: 913-917
53 Brown GC. Retinal vascular diseases. J Ophthalmic Nurs Technol 1991; 10: 71-75
54 Mason JO, Shah AA, Vail RS. et al. Branch retinal artery occlusion: visual prognosis. Am J Ophthalmol 2008; 146: 455-457
55 Fraser S, Siriwardena D. Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev 2002; (01) CD001989
56 Varma DD, Cugati S, Lee AW. et al. A review of central retinal artery occlusion: clinical presentation and management. Eye (Lond) 2013; 27: 688-697
57 Pielen A, Junker B, Hansen L. et al. Diagnostik und Therapie beim nicht arteriitischen Zentralarterienverschluss. Klin Monatsbl Augenheilkd 2010; 227: 712-720
58 Feltgen N, Schmidt D, Hansen L. Arterielle retinale Verschlusse. Ophthalmologe 2003; 100: 651-665 quiz 666–667
59 Hollenhorst RW. Significance of bright plaques in the retinal arterioles. Trans Am Ophthalmol Soc 1961; 59: 252-273
60 Hayreh SS. Comment re: multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. Graefes Arch Clin Exp Ophthalmol 2007; 245: 464-466
61 Noble J, Weizblit N, Baerlocher MO. et al. Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review. Br J Ophthalmol 2008; 92: 588-593
62 Fieß A, Cal O, Kehrein S. et al. Anterior chamber paracentesis after central retinal artery occlusion: a tenable therapy?. BMC Ophthalmol 2014; 14: 28
63 Barbón-García JJ, Alvarez-Suárez ML. [Paracentesis and ocular massage as treatment of central retinal artery occlusion]. Arch Soc Esp Oftalmol 2007; 82: 657-659
64 Mueller A, Neubauer A, Schaller U. et al. Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol 2003; 121: 1377-1381
65 Duxbury O, Bhogal P, Cloud G. et al. Successful treatment of central retinal artery thromboembolism with ocular massage and intravenous acetazolamide. BMJ Case Rep 2014; 2014
66 Schmidt D. Ocular massage in a case of central retinal artery occlusion the successful treatment of a hitherto undescribed type of embolism. Eur J Med Res 2000; 5: 157-164
67 Cope A, Eggert JV, OʼBrien E. Retinal artery occlusion: visual outcome after treatment with hyperbaric oxygen. Diving Hyperb Med 2011; 41: 135-138
68 Menzel-Severing J, Siekmann U, Weinberger A. et al. Early hyperbaric oxygen treatment for nonarteritic central retinal artery obstruction. Am J Ophthalmol 2012; 153: 454-459.e2
69 Aisenbrey S, Krott R, Heller R. et al. [Hyperbaric oxygen therapy in retinal artery occlusion]. Ophthalmol Z Dtsch Ophthalmol Ges 2000; 97: 461-467
70 Weiss JN. Hyperbaric oxygen treatment of nonacute central retinal artery occlusion. Undersea Hyperb Med J Undersea Hyperb Med Soc Inc 2009; 36: 401-405
71 Bertram B, Wolf S, Fisches H. et al. [Thrombolytic treatment of retinal arterial occlusions with plasminogen activator]. [German]. Klin Monatsbl Augenheilkd 1991; 198: 295-300
72 Feltgen N, Schmidt D, Schumacher M. Response to comment: Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE-Group) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE study report no. 1. Graefes Arch Clin Exp Ophthalmol 2007; 245: 467-470
73 Deutsche Schlaganfall Gesellschaft. Sekundärprophylaxe ischämischer Schlaganfall und transitorische ischämische Attacke. AWMF-Register 2015; Nr. 030 – 133.
74 Feltgen N, Neubauer A, Jurklies B. et al. Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1. Graefes Arch Clin Exp Ophthalmol 2006; 244: 950-956
75 Beatty S, Au Eong KG. Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. Br J Ophthalmol 2000; 84: 914-916
76 Hazin R, Dixon JA, Bhatti MT. Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy?. Curr Opin Ophthalmol 2009; 20: 210-218
77 Vallee JN, Aymard A, Paques M. et al. [Value of local ophthalmic artery fibrinolysis in severe forms of central retinal vein occlusion]. J Radiol 2001; 82: 137-144
78 Von Mach M-A, Güz A, Wiechelt J. et al. [Systemic fibrinolytic therapy using urokinase in central retinal artery occlusion. A case study] 1946. Dtsch Med Wochenschr 2005; 130: 1002-1006
79 Schumacher M, Schmidt D, Jurklies B. et al. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 2010; 117: 1367-1375.e1
80 Chen CS, Lee AW, Campbell B. et al. Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial. Stroke J Cereb Circ 2011; 42: 2229-2234
81 Hattenbach L-O, Kuhli-Hattenbach C, Scharrer I. et al. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion. Am J Ophthalmol 2008; 146: 700-706
82 Schrag M, Youn T, Schindler J. et al. Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis. JAMA Neurol 2015; 72: 1148-1154
83 Schmidt DP, Schulte-Monting J, Schumacher M. Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. Ajnr Am J Neuroradiol 2002; 23: 1301-1307
84 Kiesewetter H, Blume J, Jung F. et al. Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage II b. J Intern Med 1990; 227: 107-114
85 Roth S. The effects of isovolumic hemodilution on ocular blood flow. Exp Eye Res 1992; 55: 59-63
86 Neely KA, Ernest JT, Goldstick TK. et al. Isovolemic hemodilution increases retinal tissue oxygen tension. Graefes Arch Clin Exp Ophthalmol 1996; 234: 688-694
87 Rüfer F, Schröder A, Winter R. et al. [Analysis of risk factors and comparison of heparin and hemodilution therapies for retinal artery occlusion]. Ophthalmol Z Dtsch Ophthalmol Ges 2003; 100: 819-824
88 Wiederholt M, Leonhardt H, Schmid-Schönbein H. et al. [Treatment of central retinal venous and arterial occlusion by isovolemic hemodilution (authorʼs transl)]. Klin Monatsbl Augenheilkd 1980; 177: 157-164
89 Wolf S, Hoberg A, Bertram B. et al. [Video fluorescein angiography follow-up of patients with retinal artery occlusion]. [German]. Klin Monatsbl Augenheilkd 1989; 195: 154-160
90 Arend O, Hoberg A, Bertram B. et al. [Hemodilution in acute arterial circulatory disorders of the retina]. [German]. Acta Med Austriaca 1991; 18: 66-68
91 Diener H-C, Aisenberg J, Ansell J. et al. Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. Eur Heart J online publication 04.02.2016;
92 Diener H-C, Aisenberg J, Ansell J. et al. Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. Eur Heart J online publication 04.02.2016;
93 Diener H-C, Kleinschnitz C. Non-vitamin K oral anticoagulants in stroke patients: practical issues. J Stroke 2016; 18: 138-145
94 Sandercock P, Gubitz G, Foley P. et al. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2003; (02) CD000029
95 Rothwell PM, Algra A, Chen Z. et al. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet 2016; 388: 365-375
96 Frayser R, Saltzman HA, Anderson B. et al. The effect of hyperbaric oxygenation on retinal circulation. Arch Ophthalmol 1967; 77: 265-269
97 Nichols CW, Lambertsen C. Effects of high oxygen pressures on the eye. N Engl J Med 1969; 281: 25-30
98 Oguz H, Sobaci G. The use of hyperbaric oxygen therapy in ophthalmology. Surv Ophthalmol 2008; 53: 112-120
99 Butler FK, Hagan C, Murphy-Lavoie H. Hyperbaric oxygen therapy and the eye. Undersea Hyperb Med J Undersea Hyperb Med Soc Inc 2008; 35: 333-387
100 Murphy-Lavoie H, Butler F, Hagan C. Central retinal artery occlusion treated with oxygen: a literature review and treatment algorithm. Undersea Hyperb Med J Undersea Hyperb Med Soc Inc 2012; 39: 943-953
101 Jampol LM. Oxygen therapy and intraocular oxygenation. Trans Am Ophthalmol Soc 1987; 85: 407-437
102 Gaydar V, Ezrachi D, Dratviman-Storobinsky O. et al. Reduction of apoptosis in ischemic retinas of two mouse models using hyperbaric oxygen treatment. Invest Ophthalmol Vis Sci 2011; 52: 7514-7522
103 Christiansen CB, Lip GYH, Lamberts M. et al. Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation. J Thromb Haemost JTH 2013; 11: 1485-1492
104 Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 2003; 136: 1136-1150
105 Bertram B, Remky A, Arend O. et al. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases. Ger J Ophthalmol 1995; 4: 332-335
106 Marcucci R, Sodi A, Giambene B. et al. Cardiovascular and thrombophilic risk factors in patients with retinal artery occlusion. Blood Coagul Fibrinolysis Int J Haemost Thromb 2007; 18: 321-326
107 BVA und DOG. Anteriore ischämische Opticus-Neuropathie (AION), Leitlinie Nr 29. 2001. http://augeninfo.de/leit/leitlinie.php?nr=leit29 Stand: 04.01.2017
108 Duker JS, Brown GC. Neovascularization of the optic disc associated with obstruction of the central retinal artery. Ophthalmology 1989; 96: 87-91
109 Sivalingam A, Brown GC, Magargal LE. The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment. Int Ophthalmol 1991; 15: 15-20
110 Sivalingam A, Brown GC, Magargal LE. et al. The ocular ischemic syndrome. II. Mortality and systemic morbidity. Int Ophthalmol 1989; 13: 187-191